PERRIGO Co plc (PRGO) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, PERRIGO reported revenue of $4.25B, down 2.8% from $4.37B the year before. Net income was -$1.43B (a -33.5% net margin), or -$10.29 per diluted share. Gross margin was 35.1% and operating margin was -26.4%. Operating activities generated $238.5M of cash, leaving $145.1M of free cash flow. At fiscal year end, PERRIGO held $8.54B in total assets against $5.60B in total liabilities.
Open the full interactive PERRIGO financials → Quarterly statements, key ratios, valuation history and price charts.
PERRIGO Key Stats
| Share Price | $15.37 |
|---|---|
| Market Cap | $2.15B |
| Dividend Yield | 7.45% |
| Revenue YoY Growth | -2.8% |
| 52-Week Range | $8.83 – $20.49 |
| Shares Outstanding | 139.1 million (basic, 2026 Q2) |
PERRIGO Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $5.06B | $4.14B | $4.45B | $4.66B | $4.37B | $4.25B |
| Cost of Goods Sold | $3.25B | $2.72B | $3.00B | $2.98B | $2.83B | $2.76B |
| Gross Profit | $1.82B | $1.42B | $1.46B | $1.68B | $1.54B | $1.49B |
| Operating Income | $115.4M | $410.4M | $78.9M | $151.9M | $112.9M | -$1.12B |
| Pre-Tax Income | -$149.4M | $320.7M | -$148.8M | -$8.3M | -$80.7M | -$1.30B |
| Income Tax | $13.2M | $389.6M | -$8.2M | -$3.9M | $80.0M | $104.4M |
| Net Income | -$162.6M | -$68.9M | -$140.6M | -$12.7M | -$171.8M | -$1.43B |
| Diluted EPS | -$1.19 | -$0.52 | -$1.04 | -$0.09 | -$1.25 | -$10.29 |
PERRIGO Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.04B | $1.11B | $969.2M | $1.02B |
| Net Income | $7.5M | -$1.42B | -$398.6M | $74.5M |
| Diluted EPS | $0.05 | -$10.24 | -$2.87 | $0.53 |
PERRIGO Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $641.5M | $1.86B | $600.7M | — | — | — |
| Current Assets | $3.13B | $3.86B | $2.72B | $2.83B | $2.48B | $2.80B |
| Total Assets | $11.49B | $10.43B | $11.02B | $10.81B | $9.65B | $8.54B |
| Current Liabilities | $1.38B | $1.59B | $1.11B | $1.59B | $1.04B | $1.01B |
| Total Long-Term Debt | $3.57B | $3.52B | $4.11B | $4.07B | $3.62B | $3.64B |
| Total Liabilities | $5.83B | $5.27B | $6.18B | $6.04B | $5.33B | $5.60B |
| Shareholders' Equity | $5.66B | $5.15B | $4.84B | $4.77B | $4.32B | $2.94B |
PERRIGO Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $636.2M | $156.3M | $307.3M | $405.5M | $362.9M | $238.5M |
| Cash From Investing | -$187.8M | $1.28B | -$1.96B | -$77.5M | $78.8M | -$75.4M |
| Cash From Financing | -$181.1M | -$178.7M | $421.6M | -$187.2M | -$611.0M | -$220.5M |
| Free Cash Flow | $465.8M | $4.2M | $210.9M | $303.8M | $244.6M | $145.1M |
| Dividends Paid | $123.9M | $129.6M | $142.4M | $149.7M | $152.5M | $159.3M |
Figures from PERRIGO's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full PERRIGO financials page for every line item.
PERRIGO Company Profile
| Ticker | PRGO |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | Dublin 2, Ireland |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001585364 |
Frequently Asked Questions
What was PERRIGO's revenue in fiscal 2025?
PERRIGO (PRGO) reported revenue of $4.25B for fiscal 2025.
What is PERRIGO's annual revenue history?
PERRIGO's annual revenue by fiscal year: 2020: $5.06B; 2021: $4.14B; 2022: $4.45B; 2023: $4.66B; 2024: $4.37B; 2025: $4.25B.
What was PERRIGO's net income in fiscal 2025?
PERRIGO reported net income of -$1.43B for fiscal 2025.
What was PERRIGO's earnings per share (EPS) in fiscal 2025?
PERRIGO's diluted EPS was -$10.29 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did PERRIGO generate in fiscal 2025?
PERRIGO generated $145.1M of free cash flow in fiscal 2025.
What was PERRIGO's revenue last quarter?
In its most recent reported quarter (2026 Q2), PERRIGO reported revenue of $1.02B.
How much debt does PERRIGO have?
PERRIGO reported $3.64B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of PERRIGO are outstanding?
PERRIGO reported a weighted average of 139.1 million basic shares outstanding in 2026 Q2.
What is PERRIGO's market cap?
Based on its latest closing price, PERRIGO (PRGO) has a market capitalization of about $2.15B.
When does PERRIGO's fiscal year end?
PERRIGO's fiscal year end, as registered with the SEC, is December 31.
Where is PERRIGO headquartered?
PERRIGO lists its business address in Dublin 2, Ireland in its SEC filings.